Cachet Pharmaceutical Co., Ltd. (SHE:002462)
China flag China · Delayed Price · Currency is CNY
10.13
-0.17 (-1.65%)
Nov 18, 2026, 3:05 PM CST

Cachet Pharmaceutical Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Revenue
17,22719,50723,98529,92326,22025,626
Other Revenue
18.4118.4133.9673.25--
17,24619,52524,01929,99626,22025,626
Revenue Growth
-13.72%-18.71%-19.93%14.40%2.32%10.19%
Cost of Revenue
16,29118,33622,43128,07724,11623,493
Gross Profit
954.651,1891,5881,9192,1042,133
Selling, General & Admin
497.33533.28882.781,0521,1531,088
Other Operating Expenses
64.5833.2748.4350.6345.844.73
Operating Expenses
781.33813.621,0271,1871,2731,159
Operating Income
173.32375.1561.28732.78831973.49
Interest Expense
-47.16-82.6-129.18-166.35-188.57-164.24
Interest & Investment Income
19.7315.619.4831.1222.4318.66
Currency Exchange Gain (Loss)
---0.210.570.18-0.66
Other Non Operating Income (Expenses)
-11.84-15.85-26.62-29.13-30.96-12.17
EBT Excluding Unusual Items
134.06292.25424.74568.99634.08815.08
Impairment of Goodwill
-48.94-48.94-80.41-40.05-20.21-13.71
Gain (Loss) on Sale of Investments
-0.04-0.030.04-3.5-2.63-0.52
Gain (Loss) on Sale of Assets
1.434.31201.430.851.670.74
Asset Writedown
-60.53-0.18-6.14-0.3-1.88-0.21
Other Unusual Items
45.4630.697.0529.2933.8822.59
Pretax Income
71.44278.09546.7555.28644.91823.98
Income Tax Expense
158.44176.38229.99178.75176.59222.1
Earnings From Continuing Operations
-87101.71316.71376.53468.31601.88
Minority Interest in Earnings
101.969.67-158.57-126.47-171.38-248
Net Income
14.96111.38158.14250.06296.94353.88
Net Income to Common
14.96111.38158.14250.06296.94353.88
Net Income Growth
-78.16%-29.57%-36.76%-15.79%-16.09%11.43%
Shares Outstanding (Basic)
297293293291291292
Shares Outstanding (Diluted)
297293293291291292
Shares Change
0.82%0.09%0.71%-0.12%-0.46%0.38%
EPS (Basic)
0.050.380.540.861.021.21
EPS (Diluted)
0.050.380.540.861.021.21
EPS Growth
-78.34%-29.63%-37.21%-15.69%-15.70%11.01%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
1,1391,369164.931,396-351.98666.17
Free Cash Flow Per Share
3.844.670.564.80-1.212.28
Dividend Per Share
0.1150.1150.1700.2600.3100.370
Dividend Growth
-32.35%-32.35%-34.62%-16.13%-16.22%12.12%
Gross Margin
5.54%6.09%6.61%6.40%8.03%8.32%
Operating Margin
1.00%1.92%2.34%2.44%3.17%3.80%
Profit Margin
0.09%0.57%0.66%0.83%1.13%1.38%
Free Cash Flow Margin
6.61%7.01%0.69%4.65%-1.34%2.60%
EBITDA
174.23398.49614.64866.17989.041,114
EBITDA Margin
1.01%2.04%2.56%2.89%3.77%4.35%
D&A For EBITDA
0.9123.3953.36133.39158.03140.26
EBIT
173.32375.1561.28732.78831973.49
EBIT Margin
1.00%1.92%2.34%2.44%3.17%3.80%
Effective Tax Rate
221.79%63.42%42.07%32.19%27.38%26.96%
Revenue as Reported
17,24619,52524,01929,99626,22025,626